Millions in funding and new board members for Belgian mRNA company

An mRNA technologies company has raised €39 million ($38.7 million) in a series B2 financing and gained new board members.

Related Keywords

Sweden ,Stockholm ,Belgium ,Steven Powell ,Kenneth Chien ,Novalis Lifesciences ,Bernard Sagaert ,Karolinska Institute ,Life Sciences ,Omega Fund ,Professor Kenneth Chien ,Grand Pharma ,Moderna Therapeutics ,Marijn Dekkers ,